Providing Peripheral Blood Mononuclear Cell (PBMC) isolation for accredited vaccine research trials through our national network of laboratories.
PK4 Laboratories uses our proprietary high-yield procedure to isolate PBMCs with an emphasis on high viability and recovery. As the only national network of PBMC processing labs, we work directly with research clinics and pharmaceutical sponsors to process and store cells in accordance with sponsor-provided methodology and criteria.
PK4 Laboratories operates under relevant laboratory accreditation standards including GCP and ISO17025. These standards are maintained and monitored closely at each of our locations.
Processing of whole blood samples happens directly from numerous accredited clinical sites. Isolation of cells follows either sponsor-directed operative procedures or an in-house protocol, available upon request. The average cell viability across all PK4 sites and studies stands at >96%.
Each site within the PK4 Laboratory network holds a -20°C, -80°C, and LN2 freezer for storage, whether short-term or long-term. Shipping is scheduled based on client requirements.
our research partners
With a specialized focus in PBMC isolation, we firmly believe that the advancements of pharmaceutical research is a collaborative endeavor. We extend an invitation to clinical partners interested in expanding their research portfolio into various specialties, including but not limited to vaccine and oncology trials. Reach out today.
BLOG POSTS
Stay informed on industry trends and the rigorous science behind medical innovations.
Share On: